Error message

To log in to this site, your browser must accept cookies from the domain www.nestlenutrition-institute.org.

HMOs and gut development: What is the current evidence?

Posted: Feb 25,2022

With the advancement of technology and research activities, the knowledge about how human milk oligosaccharides, or HMOs, will benefit the baby is constantly increasing, and more HMOs are available for infant nutrition. A new randomized, controlled, double-blind trial on supplementation with a unique blend of 5 HMOs shows they promote gut development in infants, by supporting the intestinal immune system, a healthy gut barrier and shaping the gut microbiome closer to that of breastfed infants. Find out more information about this clinical study in the following infographic.

HMOs and gut development_CT_FIna